Brain Tumors Meeting 2018

On June 21-23, 2018 we had a pleasure and honor to participate as one of the sponsors in the "Brain Tumors Meeting 2018 - From Biology to Therapy", which took place in Neurobiology Center, Nencki Institute of Experimental Biology. The main advantage of the conference was its high scientific quality, specialized topics focused on basic and clinical research on brain tumor biology and therapy. During the Meeting the lectures was presented by internationally recognized experts and covered recent advances in pathobiology, immunology, diagnosis and therapy of brain tumors. Complex interactions between tumor cells, microenvironment and host immunity were discussed. During this conference we have the great pleasure to present the concept of development of a new targeted drug WPD001 for treatment of glioblastoma.